Literature DB >> 17261738

Lymphocytes: potential mediators of postischemic injury and neuroprotection.

J Michael Gee1, Angela Kalil, Connor Shea, Kyra J Becker.   

Abstract

Antigen-nonspecific inflammation appears to contribute to postischemic brain injury. Because there is a breach in the integrity of the blood-brain barrier after stroke, the immune system encounters novel central nervous system (CNS) antigens that allow for the development of a CNS antigen-specific autoimmune response. The nature of the immune response generated on antigen encounter is determined by the microenvironment at the site of antigen encounter. For instance, a systemic inflammatory response, such as that which would accompany an infection, could alter the microenvironment in such a way as to promote the initiation of deleterious autoimmunity. If patients who develop an infection in the immediate poststroke period are predisposed toward a CNS autoimmune response, it might help to explain why infection after stroke is associated with increased disability. We present data to support this hypothesis and to show that the breach in the blood-brain barrier can also be capitalized on to modulate the immune response to create a neuroprotective environment after stroke.

Entities:  

Mesh:

Year:  2007        PMID: 17261738     DOI: 10.1161/01.STR.0000248425.59176.7b

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  36 in total

1.  T time in the brain.

Authors:  Eng H Lo
Journal:  Nat Med       Date:  2009-08       Impact factor: 53.440

2.  Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke.

Authors:  Wenbin Zhu; Nicole L Libal; Amanda Casper; Sheetal Bodhankar; Halina Offner; Nabil J Alkayed
Journal:  Transl Stroke Res       Date:  2014-06-24       Impact factor: 6.829

3.  A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke.

Authors:  Gil Benedek; Wenbin Zhu; Nicole Libal; Amanda Casper; Xiaolin Yu; Roberto Meza-Romero; Arthur A Vandenbark; Nabil J Alkayed; Halina Offner
Journal:  Metab Brain Dis       Date:  2014-03       Impact factor: 3.584

4.  Axonal degeneration, regeneration and ganglion cell death in a rodent model of anterior ischemic optic neuropathy (rAION).

Authors:  Cheng Zhang; Yan Guo; Bernard J Slater; Neil R Miller; Steven L Bernstein
Journal:  Exp Eye Res       Date:  2010-06-01       Impact factor: 3.467

5.  Protective conditioning of the brain: expressway or roadblock?

Authors:  Philipp Mergenthaler; Ulrich Dirnagl
Journal:  J Physiol       Date:  2011-06-27       Impact factor: 5.182

6.  Reperfusion injury intensifies the adaptive human T cell alloresponse in a human-mouse chimeric artery model.

Authors:  Tai Yi; Birgit Fogal; Zhengrong Hao; Zuzana Tobiasova; Chen Wang; Deepak A Rao; Rafia S Al-Lamki; Nancy C Kirkiles-Smith; Sanjay Kulkarni; John R Bradley; Alfred L M Bothwell; William C Sessa; George Tellides; Jordan S Pober
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-03       Impact factor: 8.311

7.  Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier.

Authors:  Danielle N Doll; Heng Hu; Jiahong Sun; Sara E Lewis; James W Simpkins; Xuefang Ren
Journal:  Stroke       Date:  2015-04-28       Impact factor: 7.914

8.  Advances in imaging of new targets for pharmacological intervention in stroke: real-time tracking of T-cells in the ischaemic brain.

Authors:  F Ortolano; P Maffia; G Dever; G Rodolico; O R Millington; M G De Simoni; J M Brewer; T J Bushell; P Garside; H V Carswell
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

9.  Recombinant T cell receptor ligand treats experimental stroke.

Authors:  Sandhya Subramanian; Bing Zhang; Yasuharu Kosaka; Gregory G Burrows; Marjorie R Grafe; Arthur A Vandenbark; Patricia D Hurn; Halina Offner
Journal:  Stroke       Date:  2009-05-14       Impact factor: 7.914

10.  Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO.

Authors:  Tobias Stubbe; Friederike Ebner; Daniel Richter; Odilo Engel; Odilo Randolf Engel; Juliane Klehmet; Georg Royl; Andreas Meisel; Robert Nitsch; Christian Meisel; Christine Brandt
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-12       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.